June 7, 2007
Kevin R. Fox, MD, Named First
Mariann T. and Robert J. MacDonald
(PHILADELPHIA) — Kevin
R. Fox, MD, Medical Director of the Rena
Rowan Breast Center at the Abramson
Cancer Center of the University of Pennsylvania, has
been named the inaugural recipient of the Mariann T. and Robert J.
MacDonald Professorship in Breast Cancer Care Excellence.
Fox has published more than 50 journal articles, 50 research abstracts,
and 20 book chapters on the treatment of breast and other cancers. In
1997, he received the Donald B. Martin Teaching Service Award from the
Department of Medicine at the University of Pennsylvania School of Medicine
and the Donna McCurdy Housestaff Teaching Award in 2001. In 2002, he
was named the I.S. Ravdin Master Clinician for the University
of Pennsylvania Health System.
The Abramson Cancer Center (ACC) of the University of Pennsylvania is a national leader in cancer research, patient care, and education. The pre-eminent position of the Cancer Center is reflected in its continuous designation as a Comprehensive Cancer Center by the National Cancer Institute for 30 years, one of 39 such Centers in the United States. The ACC is dedicated to innovative and compassionate cancer care. The clinical program, comprised of a dedicated staff of physicians, nurse practitioners, nurses, social workers, physical therapists, nutritionists and patient care coordinators, currently sees over 50,000 outpatient visits, 3400 inpatient admissions, and provides over 24,000 chemotherapy treatments, and more than 65,000 radiation treatments. Not only is the ACC dedicated to providing state-of-the-art cancer care, the latest forms of cancer prevention, diagnosis, and treatment are available to our patients through clinical themes that developed in the relentless pursuit to eliminate the pain and suffering from cancer. In addition, the ACC is home to the 300 research scientists who work relentlessly to determine the pathogenesis of cancer. Together, the faculty are committed to improving the prevention, diagnosis and treatment of cancer.
PENN Medicine is a $2.9 billion enterprise dedicated to the related missions of medical education, biomedical research, and high-quality patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.
Penn's School of Medicine is ranked #2 in the nation for receipt of NIH research funds; and ranked #3 in the nation in U.S. News & World Report's most recent ranking of top research-oriented medical schools. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.The University of Pennsylvania Health System includes three hospitals, all of which have received numerous national patient-care honors [Hospital of the University of Pennsylvania; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center]; a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice.